Back to Search Start Over

Dual role of the peptide-loading complex as proofreader and limiter of MHC-I presentation.

Authors :
Brunnberg J
Barends M
Frühschulz S
Winter C
Battin C
de Wet B
Cole DK
Steinberger P
Tampé R
Source :
Proceedings of the National Academy of Sciences of the United States of America [Proc Natl Acad Sci U S A] 2024 May 28; Vol. 121 (22), pp. e2321600121. Date of Electronic Publication: 2024 May 21.
Publication Year :
2024

Abstract

Antigen presentation via major histocompatibility complex class I (MHC-I) molecules is essential for surveillance by the adaptive immune system. Central to this process is the peptide-loading complex (PLC), which translocates peptides from the cytosol to the endoplasmic reticulum and catalyzes peptide loading and proofreading of peptide-MHC-I (pMHC-I) complexes. Despite its importance, the impact of individual PLC components on the presented pMHC-I complexes is still insufficiently understood. Here, we used stoichiometrically defined antibody-nanobody complexes and engineered soluble T cell receptors (sTCRs) to quantify different MHC-I allomorphs and defined pMHC-I complexes, respectively. Thereby, we uncovered distinct effects of individual PLC components on the pMHC-I surface pool. Knockouts of components of the PLC editing modules, namely tapasin, ERp57, or calreticulin, changed the MHC-I surface composition to a reduced proportion of HLA-A*02:01 presentation compensated by a higher ratio of HLA-B*40:01 molecules. Intriguingly, these knockouts not only increased the presentation of suboptimally loaded HLA-A*02:01 complexes but also elevated the presentation of high-affinity peptides overexpressed in the cytosol. Our findings suggest that the components of the PLC editing module serve a dual role, acting not only as peptide proofreaders but also as limiters for abundant peptides. This dual function ensures the presentation of a broad spectrum of antigenic peptides.<br />Competing Interests: Competing interests statement:B.W. and D.K.C. indicate a potential conflict of interest as former and present employee of Immunocore Ltd, respectively. The remaining authors declare no competing financial interests.

Details

Language :
English
ISSN :
1091-6490
Volume :
121
Issue :
22
Database :
MEDLINE
Journal :
Proceedings of the National Academy of Sciences of the United States of America
Publication Type :
Academic Journal
Accession number :
38771881
Full Text :
https://doi.org/10.1073/pnas.2321600121